论文信息 - S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis. - 字舞流文

S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis.

Junjian Wang | J. Zou | Jianzhen Xu | Hong-Wu Chen | Peiqing Liu | Songtao Xiang | F. Han | Qianqian Wang | Jianwei Zheng | J. Zheng | Jianwei Zheng